Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

M.Alzheimer GSK - Book 6 NCT00334568/ GSK-AVA100193 - NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Book 6

- 5/12/16 - 1 formulario, 10 itemgroups, 24 items, 1 idioma

Itemgroups: General Information, Vital Signs, Central Laboratory (Non fasting samples), Concomitant Medications, Adverse Events, Physical Examination, Pedal Oedema, Monitor Data Validation Check, Investigational Product, End of Visit Reminder

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains Book 6/Visit 6.

M.Alzheimer GSK - Book 5 NCT00334568/ GSK-AVA100193 - NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Book 5

- 5/12/16 - 1 formulario, 12 itemgroups, 25 items, 1 idioma

Itemgroups: General Information, Central Laboratory Instructions (Fasting Samples), Subject Continuation, Vital Signs, Concomitant Medications, Adverse Events, Physical Examination, Pedal Oedema, Rating scale, Validation Checks, Investigational Product, End of visit reminder

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains Book 5/Visit 5.

AN MS Pruritus HAUT FU Sub University Hospital Muenster (UKM) Subform

- 5/12/16 - 1 formulario, 9 itemgroups, 48 items, 1 idioma

Itemgroups: Medical history taking, Classification, Latest definite diagnosis, Definite diagnosis, Current status, Skin findings: Dermographism and xerosis cutis, Skin findings: Lesions caused by scratching, Skin findings: Dermatosis, Conclusion

Hospital Routine Documentation Subform at the University Hospital Muenster. Original Form name: AN MS Pruritus HAUT FU Sub.

WTZ-GIST-09-01 (Imatinib + LBH589) Final Medical Examination 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Final Medical Examination 2009-011417-24

- 2/12/16 - 1 formulario, 1 itemgroup, 16 items, 1 idioma

Itemgroup: Final medical examination

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

WTZ-GIST-09-01 (Imatinib + LBH589) Additional Cycle 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Additional Cycle 2009-011417-24

- 1/12/16 - 1 formulario, 2 itemgroups, 16 items, 1 idioma

Itemgroups: Chemotherapy Regimen, Vital signs

Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

AN MS MEDD Anamnese KU NTX University Hospital Muenster (UKM) Subform

- 30/11/16 - 1 formulario, 5 itemgroups, 125 items, 2 idiomas

Itemgroups: General information, Vegetative anamnesis and management of risk factors, Clinical examination, Sonography of transplanted kidney, Summary/Procedure

Hospital Routine Documentation Subform at the University Hospital Muenster. Original Form name: AN MS MEDD Anamnese KU NTX.